Creo Medical Limited (CREO.L)
GBp 16.25
(-5.8%)
GBp 16.25
(-5.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.9 Million | -24.98 Million | -25.98 Million | -16.08 Million | -11.54 Million | -14.19 Million |
| Net Income | -21.7 Million | -26.93 Million | -24.59 Million | -20.31 Million | -15.91 Million | -9.87 Million |
| Depreciation & Amortization | 3.4 Million | 3.11 Million | 2.56 Million | 1.59 Million | 641.72 Thousand | 331.61 Thousand |
| Deferred income taxes | 1.1 Million | 239 Thousand | -1.92 Million | 54 Thousand | -532.14 Thousand | -2.44 Million |
| Stock-based compensation | 1.2 Million | 1.4 Million | 2.56 Million | 728 Thousand | 1.55 Million | 1.2 Million |
| Change in working capital | -5.5 Million | -2.82 Million | -4.26 Million | 2.05 Million | 2.3 Million | -581.64 Thousand |
| Other non-cash items | 15.2 Million | 18 Thousand | -323 Thousand | -207 Thousand | 399.57 Thousand | -2.82 Million |
| Investing Cash Flow | -19 Million | -6.02 Million | -7.87 Million | -21.16 Million | -1.11 Million | -1.38 Million |
| Investments in PPE | -1.6 Million | -3.27 Million | -6.12 Million | -576 Thousand | -1.11 Million | -1.38 Million |
| Acquisitions | -2.4 Million | -2.75 Million | -1.75 Million | -20.58 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -15 Million | -29 Thousand | -115 Thousand | 104 Thousand | -322.5 Thousand | -133.41 Thousand |
| Financing Cash Flow | 29.8 Million | 522 Thousand | 31.99 Million | 1.32 Million | 49.11 Million | 46.48 Million |
| Debt repayment | -1.2 Million | -1.27 Million | -1.7 Million | -1.55 Million | -187.31 Thousand | -418.26 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 31.7 Million | 70 Thousand | 34.2 Million | 159 Thousand | 49.3 Million | 46.06 Million |
| Other Financing Activities | 31.7 Million | -827 Thousand | -515 Thousand | -391 Thousand | 49.11 Million | 30.98 Million |
| Accounts receivables | -1.4 Million | -1.57 Million | -3.17 Million | -394 Thousand | -552.69 Thousand | -514.25 Thousand |
| Accounts payables | -3.7 Million | -902 Thousand | 1.87 Million | 1.68 Million | 3.28 Million | 143.74 Thousand |
| Inventory | -400 Thousand | -348 Thousand | -2.96 Million | 767 Thousand | -424.68 Thousand | -211.13 Thousand |
| Other working capital | -3.7 Million | - | - | - | - | - |
| Cash at beginning of period | 13.09 Million | 43.53 Million | 45.09 Million | 81.04 Million | 44.58 Million | 13.68 Million |
| Cash at end of period | 3 Million | 13.09 Million | 43.53 Million | 45.09 Million | 81.04 Million | 44.58 Million |
| Capital Expenditure | -1.6 Million | -3.27 Million | -6.12 Million | -576 Thousand | -1.11 Million | -1.38 Million |
| Effect of forex changes on cash | - | 56 Thousand | 303 Thousand | -35 Thousand | 44.58 Million | -44.58 Million |
| Net cash flow / Change in cash | -10.09 Million | -30.43 Million | -1.55 Million | -35.95 Million | 36.45 Million | 30.89 Million |
| Free Cash Flow | -22.5 Million | -28.26 Million | -32.1 Million | -16.66 Million | -12.65 Million | -15.58 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.3 Million | -10.1 Million | -21.7 Million | -11.6 Million | -26.93 Million | -13.5 Million |
| Depreciation & Amortization | 1.8 Million | 1.7 Million | 3.4 Million | 1.7 Million | 3.11 Million | 1.66 Million |
| Deferred income taxes | - | 1.1 Million | 1.1 Million | -8 Million | 239 Thousand | 239 Thousand |
| Stock-based compensation | 600 Thousand | 600 Thousand | 1.2 Million | 600 Thousand | 1.4 Million | 600 Thousand |
| Change in working capital | -1.8 Million | -1 Million | -5.5 Million | -4 Million | -2.82 Million | -807 Thousand |
| Other non-cash items | -2 Million | 2.4 Million | 15.2 Million | 6.4 Million | 18 Thousand | 7.36 Million |
| Investing Cash Flow | 15.1 Million | -1.2 Million | -19 Million | -17.4 Million | -6.02 Million | -4.09 Million |
| Investments in PPE | -500 Thousand | -800 Thousand | -1.6 Million | -500 Thousand | -3.27 Million | -1.33 Million |
| Acquisitions | - | -500 Thousand | -2.4 Million | -1.9 Million | -2.75 Million | -2.75 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 15.6 Million | 100 Thousand | -15 Million | -15 Million | -29 Thousand | 100 Thousand |
| Financing Cash Flow | 5.5 Million | -800 Thousand | 29.8 Million | 30.6 Million | 522 Thousand | 296 Thousand |
| Debt repayment | -5.5 Million | -600 Thousand | -1.2 Million | -600 Thousand | -1.27 Million | -653 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 200 Thousand | 31.7 Million | 31.5 Million | 70 Thousand | 70 Thousand |
| Other Financing Activities | -300 Thousand | -800 Thousand | 31.7 Million | 31.5 Million | -827 Thousand | -800 Thousand |
| Accounts receivables | -1.5 Million | 400 Thousand | -1.4 Million | -1.8 Million | -1.57 Million | 1.44 Million |
| Accounts payables | -200 Thousand | -500 Thousand | -3.7 Million | -3.2 Million | -902 Thousand | -1.63 Million |
| Inventory | -300 Thousand | -1.4 Million | -400 Thousand | 1 Million | -348 Thousand | -620 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3 Million | 11.5 Million | 13.09 Million | 13.09 Million | 43.53 Million | 26.1 Million |
| Cash at end of period | 9.8 Million | 3 Million | 3 Million | 11.5 Million | 13.09 Million | 13.09 Million |
| Capital Expenditure | -500 Thousand | -800 Thousand | -1.6 Million | -500 Thousand | -3.27 Million | -1.33 Million |
| Effect of forex changes on cash | -100 Thousand | -100 Thousand | - | 100 Thousand | 56 Thousand | -38 Thousand |
| Net cash flow / Change in cash | 6.8 Million | -8.5 Million | -10.09 Million | -1.59 Million | -30.43 Million | -13 Million |
| Free Cash Flow | -14.2 Million | -7.2 Million | -22.5 Million | -15.4 Million | -28.26 Million | -10.5 Million |
2208
AAF
3858
CLH
POLR
8431